Fate Therapeutics

In News

Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

MarketBeat - Apr 17, 2026

Fate Therapeutics Details Off-the-Shelf CAR T Progress in Lupus and Solid Tumors at Needham Conference - Yahoo Finance

Yahoo Finance - Apr 16, 2026

Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at t - Sahm

Sahm - Apr 17, 2026

Fate cell therapy study targets blood cancers without chemo - Stock Titan

Stock Titan - Apr 16, 2026

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire - Apr 02, 2026

Fate Therapeutics announces data presentation of FT839 - TipRanks

TipRanks - Apr 16, 2026

Mizuho reiterates Fate Therapeutics stock rating on trial progress - Investing.com

Investing.com - Mar 24, 2026

Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences - GlobeNewswire

GlobeNewswire - Apr 09, 2026

New Fate employee gets 7,260 stock units vesting over 4 years - Stock Titan

Stock Titan - Apr 02, 2026

Fate Therapeutics Announces Data Presentation Of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate For The Broad Treatment Of Hematological Malignancies And Autoimmune Diseases Without The Need For Conditioning Chemotherapy - marketscreener.com

marketscreener.com - Apr 16, 2026

Fate Therapeutics plans appearances at 5 investor conferences by June - Stock Titan

Stock Titan - Apr 09, 2026

Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates - Yahoo Finance

Yahoo Finance - Feb 26, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment